• Patient-Derived Tumor Organoids Demonstrate Microbial Influence on Immune Function

    Bio-IT World | Researchers from the Wake Forest Institute for Regenerative Medicine and Wake Forest Organoid Research Center developed an immunoreactive tumor organoid to study microbial metabolites and their effect on immune function.

    Aug 25, 2022

  • Fluorescence-Quenched Substrates Measure Parkinson’s Disease-Related Enzymes

    Bio-IT World | Though Parkinson’s is the second most common neurodegenerative disease, scientists know little about its etiology. Hoping to discover more, a research team at Simon Fraser University in Burnaby, British Columbia, developed a new fluorescence-based blood testing method to examine PD development and progression in neurons.

    Aug 24, 2022

  • Self-Boosting Vaccines Are Near At Hand

    Bio-IT World | Researchers at the Massachusetts Institute of Technology have been working on “self-boosting” vaccines for a decade now. Thanks to the COVID-19 pandemic, curiosity about the underlying platform has piqued in First World nations where vaccination boosters now have personal everyday relevance.

    Aug 24, 2022

  • A Roadmap to Real-World Data in Drug Discovery

    Bio-IT World | Victoria Gamerman’s love of analytics and math came from her grandmother—the first mathematician she knew. Now, as the Global Head of Data Governance and Insights at Boehringer Ingelheim, she’s using that love for data to explore real-world data for drug discovery.

    Aug 23, 2022

  • Survey Suggests Alzheimer’s Research Is Missing the Boat

    Bio-IT World | A research team is advocating for a more data-driven approach to Alzheimer’s research where sets of biological pathways get grouped with mechanisms the body itself uses to ward off the disease.

    Aug 18, 2022

  • Metabolomics Crucial To Personalizing Lung Cancer Therapy

    Bio-IT World | A popular hypothesis in oncology research over the past few years is that immunotherapy works synergistically with glutaminase inhibition. Banking on that assumption, clinical trials have launched to evaluate the combination approach in patients with non-small cell lung cancer.

    Aug 17, 2022